BofA unit buys 100 $100K NHS preferred shares

Neuberger High Yield Strategies Fund Inc. (NHS) had 100 Mandatory Redeemable Preferred Shares, Series D (MRPS) acquired from it on 2026-08-28 by Bank of America NA, a wholly owned subsidiary of Bank of America Corporation.

Rhea-AI Filing Summary

Neuberger High Yield Strategies Fund Inc. (NHS) had 100 Mandatory Redeemable Preferred Shares, Series D (MRPS) acquired from it on 2026-08-28 by Bank of America NA, a wholly owned subsidiary of Bank of America Corporation. The MRPS were acquired at $100,000 per share, bringing Bank of America NA’s beneficial holdings to 500 MRPS, all reported as indirectly held by Bank of America Corporation.

Insider Trade Summary

Other: 100 shares

Other 1 txn

Insider BANK OF AMERICA CORP /DE/, BANK OF AMERICA NA

Role 10% Owner | 10% Owner

Type	Security	Shares	Price	Value
Other	Mandatory Redeemable Preferred Shares, Series D F1, F2, F3	100	--	--

Holdings After Transaction: Mandatory Redeemable Preferred Shares, Series D — 500 shares (Indirect, See Footnotes)

Footnotes (3)

1. F1. The 100 Mandatory Redeemable Preferred Shares, Series D reported as acquired in Table I represent preferred shares (the "MRPS Shares") beneficially owned by Bank of America NA ("BANA") that were acquired from Neuberger High Yield Strategies Fund (the "Issuer") at a price of $100,000 per share. Prior to this filing, BANA beneficially owned 400 MRPS Shares. BANA is a wholly owned subsidiary of Bank of America Corporation.
2. F2. This statement is jointly filed by Bank of America Corporation ("BAC") and BANA. BAC holds an indirect interest in the securities listed in Table I by virtue of its 100% ownership of its subsidiary BANA.
3. F3. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

Key Figures

MRPS Shares acquired: 100 Mandatory Redeemable Preferred Shares, Series D Price per MRPS Share: $100,000 per share MRPS Shares owned after transaction: 500 Mandatory Redeemable Preferred Shares, Series D +1 more

4 metrics

MRPS Shares acquired 100 Mandatory Redeemable Preferred Shares, Series D Acquired by Bank of America NA from Neuberger High Yield Strategies Fund Inc. on 2026-08-28

Price per MRPS Share $100,000 per share Acquisition price for MRPS Shares beneficially owned by Bank of America NA

MRPS Shares owned after transaction 500 Mandatory Redeemable Preferred Shares, Series D Total MRPS Shares beneficially owned by Bank of America NA following the reported acquisition

Restructuring-related shares 100 shares Shares associated with restructuring-type transaction code J in transaction summary

Key Terms

Mandatory Redeemable Preferred Shares, beneficially owned, Section 13(d), indirect interest

4 terms

Mandatory Redeemable Preferred Shares financial

"The 100 Mandatory Redeemable Preferred Shares, Series D reported as acquired"

A share that pays a fixed return and must be bought back by the issuer at a set time or upon a predetermined event, combining features of stock and a loan. It matters to investors because holders get priority on payments and a promised repayment date—like lending money with a scheduled payback—so these shares limit upside from company growth but reduce risk compared with ordinary shares and can affect a company’s future cash needs.

beneficially owned financial

"represent preferred shares (the "MRPS Shares") beneficially owned by Bank of America NA"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Section 13(d) regulatory

"for the purposes of Section 13(d) of the US Securities Exchange Act of 1934"

A Section 13(d) filing is a public disclosure required under U.S. securities law when a person or group acquires more than 5% of a company’s registered equity and may influence control. The filer must report who owns the shares, how they were acquired, and any plans or intentions for the company, so the market and other shareholders can see if a large buyer is attempting a takeover or other strategic move. Think of it like a formal announcement that someone has crossed a threshold and is showing their hand.

indirect interest financial

"BAC holds an indirect interest in the securities listed in Table I"

FAQ

What insider transaction did NHS report involving Bank of America on this Form 4?

The Form 4 reports that Bank of America NA acquired 100 Mandatory Redeemable Preferred Shares, Series D from Neuberger High Yield Strategies Fund Inc. on 2026-08-28 in an “other acquisition or disposition” coded as transaction type J and marked as an acquisition.

What price was paid per Mandatory Redeemable Preferred Share, Series D of NHS?

Bank of America NA acquired the Mandatory Redeemable Preferred Shares, Series D of NHS at a price of $100,000 per share, as disclosed in the footnotes describing the MRPS Shares beneficially owned and acquired from Neuberger High Yield Strategies Fund Inc.

How many NHS Mandatory Redeemable Preferred Shares does Bank of America NA own after this transaction?

After acquiring 100 additional MRPS Shares, Bank of America NA beneficially owns 500 Mandatory Redeemable Preferred Shares, Series D of Neuberger High Yield Strategies Fund Inc., according to the total shares following the reported transaction on the Form 4.

How is Bank of America Corporation related to the NHS MRPS shares reported on this Form 4?

Bank of America Corporation indirectly holds an interest in the NHS MRPS Shares through its 100% ownership of its subsidiary Bank of America NA. The filing states that the Form 4 is jointly filed by Bank of America Corporation and Bank of America NA.

Does this NHS Form 4 state that the reporting persons are part of a group under Section 13(d)?

No. The reporting persons expressly state that filing this Form 4 should not be construed as an admission that they are acting as a group for purposes of Section 13(d) of the U.S. Securities Exchange Act of 1934 or for any other purpose.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 12:41 PM Accepted by SEC EDGAR 09/01/2026 - 12:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last) (First) (Middle)

BANK OF AMERICA CORPORATE CENTER

100 N TRYON ST

(Street)

CHARLOTTE NORTH CAROLINA 28255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuberger High Yield Strategies Fund Inc. [ NHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Mandatory Redeemable Preferred Shares, Series D	08/28/2026		J(1)(2)		100(1)	A	(1)	500	I	See Footnotes(2)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last) (First) (Middle)

BANK OF AMERICA CORPORATE CENTER

100 N TRYON ST

(Street)

CHARLOTTE NORTH CAROLINA 28255

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BANK OF AMERICA NA

(Last) (First) (Middle)

100 NORTH TRYON STREET

(Street)

CHARLOTTE NORTH CAROLINA 28255

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The 100 Mandatory Redeemable Preferred Shares, Series D reported as acquired in Table I represent preferred shares (the "MRPS Shares") beneficially owned by Bank of America NA ("BANA") that were acquired from Neuberger High Yield Strategies Fund (the "Issuer") at a price of $100,000 per share. Prior to this filing, BANA beneficially owned 400 MRPS Shares. BANA is a wholly owned subsidiary of Bank of America Corporation.

2. This statement is jointly filed by Bank of America Corporation ("BAC") and BANA. BAC holds an indirect interest in the securities listed in Table I by virtue of its 100% ownership of its subsidiary BANA.

3. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

	BANK OF AMERICA CORP /DE/ By: Its: Authorized Signatory /s/ Christopher Twomey	09/01/2026
	BANK OF AMERICA NA By: Its: Authorized Signatory /s/ Christopher Twomey	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)